Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication

Journal of Virology

Volumn 81, Issue 3, 2007, Pages 1195-1208

  Lu, Chih Chung ^a   Huang, Ho Ting ^a   Wang, Jiin Tarng ^a   Slupphaug, Geir ^b   Li, Tsai Kun ^a   Wu, Meng Chuan ^a   Chen, Yi Chun ^a   Lee, Chung Pei ^a   Chen, Mei Ru ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA POLYMERASE; DOUBLE STRANDED DNA; INHIBITOR PROTEIN; NALIDIXIC ACID; PROTEIN BKRF3; PROTEIN RTA; PROTEIN UGI; RIFAMPICIN; SINGLE STRANDED DNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; URACIL; URACIL DNA GLYCOSIDASE; VIRUS DNA; VIRUS PROTEIN;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; BACTERIUM MUTANT; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; VIRUS REPLICATION;

CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; URACIL-DNA GLYCOSIDASE; VIRUS REPLICATION;

DNA VIRUSES; ESCHERICHIA COLI; HUMAN HERPESVIRUS 4;

EID: 33846508516     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01518-06     Document Type: Article

References (83)

1. Aravind, L., and E. V. Koonin. 2000. The alpha/beta fold uracil DNA glycosylases: a common origin with diverse fates. Genome Biol. 1:research0007.1-research0007.8. doi:10.1186/gb-2000-1-4-research0007.
2. Babcock, G. J., L. L. Decker, M. Volk, and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
3. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
4. Bennett, S. E., and D. W. Mosbaugh. 1992. Characterization of the Escherichia coli uracil-DNA glycosylase inhibitor protein complex. J. Biol. Chem. 267:22512-22521.
5. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
6. Chang, J. T. 2004. An economic and efficient method of RNAi vector constructions. Anal. Biochem. 334:199-200.
7. Chang, Y., S. S. Chang, H. H. Lee, S. L. Doong, K. Takada, and C. H. Tsai. 2004. Inhibition of the Epstein-Ban virus lytic cycle by Zta-targeted RNA interference. J. Gen. Virol. 85:1371-1379.
8. Chang, Y., S. D. Cheng, and C. H. Tsai. 2002. Chromosomal integration of Epstein-Barr virus genomes in nasopharyngeal carcinoma cells. Head Neck 24:143-150.
9. Chang, Y., C. H. Tung, Y. T. Huang, J. Lu, J. Y. Chen, and C. H. Tsai. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J. Virol. 73:8857-8866.
10. Courcelle, C. T., J. Courcelle, M. N. Prichard, and E. S. Mocarski. 2001. Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J. Virol. 75:7592-7601.
11. Daikoku, T., A. Kudoh, Y. Sugaya, S. Iwahori, N. Shirata, H. Isomura, and T. Tsurumi. 2006. Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments. J. Biol. Chem. 281:11422-11430.
12. de Jesus, O., P. R. Smith, L. C. Spender, C. Elgueta Karstegl, H. H. Niller, D. Huang, and P. J. Farrell. 2003. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 84:1443-1450.
13. Dellemijn, P. L., A. Brandenburg, H. G. Niesters, M. J. van den Bent, P. H. Rothbarth, and L. T. Vlasveld. 1995. Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant. Bone Marrow Transplant. 16:311-312.
14. De Silva, F. S., and B. Moss. 2003. Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: catalytic site mutations reduce virulence but not virus replication in cultured cells. J. Virol. 77:159-166.
15. Epeldegui, M., Y. P. Hung, A. McQuay, R. F. Ambinder, and O. Martinez-Maza. 2007. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol. Immunol. 44:934-942.
16. Fischer, J. A., S. Muller-Weeks, and S. Caradonna. 2004. Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle. DNA Repair (Amsterdam) 3:505-513.
17. Fisher, M., I. R. Shenker, and M. P. Nussbaum. 1980. Infectious mononucleosis; review of complications in hospitalized series. N. Y. State J. Med. 80:929-934.
18. Fixman, E. D., G. S. Hayward, and S. D. Hayward. 1995. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69:2998-3006.
19. Focher, F., P. Mazzarello, A. Verri, U. Hubscher, and S. Spadari. 1990. Activity profiles of enzymes that control the uracil incorporation into DNA during neuronal development. Mutat. Res. 237:65-73.
20. Focher, F., A. Verri, S. Verzeletti, P. Mazzarello, and S. Spadari. 1992. Uracil in OriS of herpes simplex 1 alters its specific recognition by origin binding protein (OBP): does virus induced uracil-DNA glycosylase play a key role in viral reactivation and replication? Chromosoma 102:S67-S71.
21. Grose, C. 1989. Neurologic compications of infectious mononucleosis, p. 49-68. In D. Schlossberg (ed.), Infectious mononucleosis, 2nd ed. Praeger, New York, NY.
22. Guillet, M., and S. Boiteux. 2003. Origin of endogenous DNA abasic sites in Saccharomyces cerevisiae. Mol. Cell. Biol. 23:8386-8394.
23. He, B., N. Raab-Traub, P. Casali, and A. Cerutti. 2003. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171:5215-5224.
24. Hochberg, D., J. M. Middeldorp, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2004. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. USA 101:239-244.
25. Imai, K., G. Slupphaug, W. I. Lee, P. Revy, S. Nonoyama, N. Catalan, L. Yel, M. Forveille, B. Kavli, H. E. Krokan, H. D. Ochs, A. Fischer, and A. Durandy. 2003. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4:1023-1028.
26. Imai, S., N. Usui, M. Sugiura, T. Osato, T. Sato, H. Tsutsumi, N. Tachi, S. Nakata, T. Yamanaka, S. Chiba, et al. 1993. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J. Med. Virol. 40:278-284.
27. Joseph, A. M., G. J. Babcock, and D. A. Thorley-Lawson. 2000. EBV persistence involves strict selection of latently infected B cells. J. Immunol. 165:2975-2981.
28. Kavli, B., O. Sundheim, M. Akbari, M. Otterlei, H. Nilsen, F. Skorpen, P. A. Aas, L. Hagen, H. E. Krokan, and G. Slupphaug. 2002. hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J. Biol. Chem. 277:39926-39936.
29. Ko, R., and S. E. Bennett. 2005. Physical and functional interaction of human nuclear uracil-DNA glycosylase with proliferating cell nuclear antigen. DNA Repair (Amsterdam) 4:1421-1431.
30. Krajewski, S., S. Tanaka, S. Takayama, M. J. Schibler, W. Fenton, and J. C. Reed. 1993. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701-4714.
31. Krokan, H. E., F. Drablos, and G. Slupphaug. 2002. Uracil in DNA-occurrence, consequences and repair. Oncogene 21:8935-8948.
32. Krokan, H. E., R. Standal, and G. Slupphaug. 1997. DNA glycosylases in the base excision repair of DNA. Biochem. J. 325:1-16.
33. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
34. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79:1296-1307.
35. Lin, C. T., W. Y. Chan, W. Chen, H. M. Huang, H. C. Wu, M. M. Hsu, S. M. Chuang, and C. C. Wang. 1993. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab. Investig. 68:716-727.
36. Lindahl, T. 1993. Instability and decay of the primary structure of DNA. Nature 362:709-715.
37. Liu, M. T., Y. T. Chang, S. C. Chen, Y. C. Chuang, Y. R. Chen, C. S. Lin, and J. Y. Chen. 2005. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity. Oncogene 24:2635-2646.
38. Liu, M. T., Y. R. Chen, S. C. Chen, C. Y. Hu, C. S. Lin, Y. T. Chang, W. B. Wang, and J. Y. Chen. 2004. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene 23:2531-2539.
39. Liu, M. Y., W. H. Chou, L. Nutter, M. M. Hsu, J. Y. Chen, and C. S. Yang. 1989. Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma. J. Med. Virol. 28:101-105.
40. Lo, Y. M., L. Y. Chan, A. T. Chan, S. F. Leung, K. W. Lo, J. Zhang, J. C. Lee, N. M. Hjelm, P. J. Johnson, and D. P. Huang. 1999. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 59:5452-5455.
41. Lu, C. C., and M. R. Chen. 2006. Lytic replication of Epstein-Barr virus. Future Virol. 1:435-446.
42. Lu, C. C., Y. Y. Jeng, C. H. Tsai, M. Y. Liu, S. W. Yeh, T. Y. Hsu, and M. R. Chen. 2006. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345:358-372.
43. Lu, C. C., C. W. Wu, S. C. Chang, T. Y. Chen, C. R. Hu, M. Y. Yeh, J. Y. Chen, and M. R. Chen. 2004. Epstein-Barr virus nuclear antigen 1 is a DNA-binding protein with strong RNA-binding activity. J. Gen. Virol. 85:2755-2765.
44. Makarova, O., E. Kamberov, and B. Margolis. 2000. Generation of deletion and point mutations with one primer in a single cloning step. BioTechniques 29:970-972.
45. Mol, C. D., A. S. Arvai, R. J. Sanderson, G. Slupphaug, B. Kavli, H. E. Krokan, D. W. Mosbaugh, and J. A. Tainer. 1995. Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA. Cell 82:701-708.
46. Mullaney, J., H. W. Moss, and D. J. McGeocb. 1989. Gene UL2 of herpes simplex virus type 1 encodes a uracil-DNA glycosylase. J. Gen. Virol. 70:449-454.
47. Nilsen, H., M. Otterlei, T. Haug, K. Solum, T. A. Nagelhus, F. Skorpen, and H. E. Krokan. 1997. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 25:750-755.
48. Olsen, L. C., R. Aasland, H. E. Krokan, and D. E. Helland. 1991. Human uracil-DNA glycosylase complements E. coli ung mutants. Nucleic Acids Res. 19:4473-4478.
49. Olsen, L. C., R. Aasland, C. U. Wittwer, H. E. Krokan, and D. E. Helland. 1989. Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme. EMBO J. 8:3121-3125.
50. Otterlei, M., E. Warbrick, T. A. Nagelhus, T. Haug, G. Slupphaug, M. Akbari, P. A. Aas, K. Steinsbekk, O. Bakke, and H. E. Krokan. 1999. Postreplicative base excision repair in replication foci. EMBO J. 18:3834-3844.
51. Pearl, L. H. 2000. Structure and function in the uracil-DNA glycosylase superfamily. Mutat. Res. 460:165-181.
52. Prichard, M. N., G. M. Duke, and E. S. Mocarski. 1996. Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J. Virol. 70:3018-3025.
53. Prichard, M. N., H. Lawlor, G. M. Duke, C. Mo, Z. Wang, M. Dixon, G. Kemble, and E. R. Kern. 2005. Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virol. J. 2:55.
54. Pulvertaft, J. V. 1965. A study of malignant tumours in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:261-273.
55. Pyles, R. B., and R. L. Thompson. 1994. Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J. Virol. 68:4963-4972.
56. Ragoczy, T., L. Heston, and G. Miller. 1998. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol. 72:7978-7984.
57. Ramiro, A. R., M. Jankovic, E. Callen, S. Difilippantonio, H. T. Chen, K. M. McBride, T. R. Eisenreich, J. Chen, R. A. Dickins, S. W. Lowe, A. Nussenzweig, and M. C. Nussenzweig. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440:105-109.
58. Ramiro, A. R., M. Jankovic, T. Eisenreich, S. Difilippantonio, S. Chen-Kiang, M. Muramatsu, T. Honjo, A. Nussenzweig, and M. C. Nussenzweig. 2004. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118:431-438.
59. Ranneberg-Nilsen, T., M. Bjoras, L. Luna, R. Slettebakk, H. A. Dale, E. Seeberg, and H. Rollag. 2006. Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells. Virology 348:389-397.
60. Rickinson, A. B., and E. Kieff. 2001. Epstin-Barr virus and its replication, 4th ed., vol. 2. Lippincott-Raven, Philadelphia, PA.
61. Savva, R., K. McAuley-Hecht, T. Brown, and L. Pearl. 1995. The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature 373:487-493.
62. Savva, R., and L. H. Pearl. 1995. Nucleotide mimicry in the crystal structure of the uracil-DNA glycosylase-uracil glycosylase inhibitor protein complex. Nat. Struct. Biol. 2:752-757.
63. Seal, G., and M. A. Sirover. 1986. Physical association of the human base-excision repair enzyme uracil DNA glycosylase with the 70,000-dalton catalytic subunit of DNA polymerase alpha. Proc. Natl. Acad. Sci. USA 83:7608-7612.
64. Slupphaug, G., I. Eftedal, B. Kavli, S. Bharati, N. M. Helle, T. Haug, D. W. Levine, and H. E. Krokan. 1995. Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase. Biochemistry 34:128-138.
65. Slupphaug, G., C. D. Mol, B. Kavli, A. S. Arvai, H. E. Krokan, and J. A. Tainer. 1996. A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA. Nature 384:87-92.
66. Slupphaug, G., L. C. Olsen, D. Helland, R. Aasland, and H. E. Krokan. 1991. Cell cycle regulation and in vitro hybrid arrest analysis of the major human uracil-DNA glycosylase. Nucleic Acids Res. 19:5131-5137.
67. Stanitsa, E. S., L. Arps, and P. Traktman. 2006. Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase. J. Biol. Chem. 281:3439-3451.
68. Takada, K., K. Horinouchi, Y. Ono, T. Aya, T. Osato, M. Takahashi, and S. Hayasaka. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156.
69. Taub, R., I. Kirsch, C. Morton, G. Lenoir, D. Swan, S. Tronick, S. Aaronson, and P. Leder. 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 79:7837-7841.
70. Taylor, T. J., and D. M. Knipe. 2004. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 78:5856-5866.
71. Tsai, C. H., M. T. Liu, M. R. Chen, J. Lu, H. L. Yang, J. Y. Chen, and C. S. Yang. 1997. Characterization of monoclonal antibodies to the Zta and DNase proteins of Epstein-Barr virus. J. Biomed. Sci. 4:69-77.
72. Tsai, C. H., M. V. Williams, and R. Glaser. 1991. Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function. J. Virol. Methods 33:47-52.
73. Verma, S. C., B. G. Bajaj, Q. Cai, H. Si, T. Seelhammer, and E. S. Robertson. 2006. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus. J. Virol. 80:11178-11190.
74. Verri, A., P. Mazzarello, G. Biamonti, S. Spadari, and F. Focher. 1990. The specific binding of nuclear protein(s) to the cAMP responsive element (CRE) sequence (TGACGTCA) is reduced by the misincorporation of U and increased by the deamination of C. Nucleic Acids Res. 18:5775-5780.
75. Verri, A., S. Verzeletti, P. Mazzarello, S. Spadari, M. Negri, G. Bunone, G. Della Valle, U. Hubscher, and F. Focber. 1992. DNA synthesis enzymes and proliferating cell nuclear antigen in normal and neoplastic nerve cells. Anticancer Res. 12:1099-1105.
76. Volpi, A. 2004. Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system. Herpes 11(Suppl. 2):120A-127A.
77. Wang, J. T., P. W. Yang, C. P. Lee, C. H. Han, C. H. Tsai, and M. R. Chen. 2005. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86:3215-3225.
78. Wang, Z., and D. W. Mosbaugh. 1989. Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. J. Biol. Chem. 264:1163-1171.
79. Wang, Z. G., D. G. Smith, and D. W. Mosbaugh. 1991. Overproduction and characterization of the uracil-DNA glycosylase inhibitor of bacteriophage PBS2. Gene 99:31-37.
80. Wilkinson, D. E., and S. K. Weller. 2004. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J. Virol. 78:4783-4796.
81. Xiao, G., M. Tordova, J. Jagadeesh, A. C. Drohat, J. T. Stivers, and G. L. Gilliland. 1999. Crystal structure of Escherichia coli uracil DNA glycosylase and its complexes with uracil and glycerol: structure and glycosylase mechanism revisited. Proteins 35:13-24.
82. Yuan, J., E. Cahir-McFarland, B. Zhao, and E. Kieff. 2006. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 80:2548-2565.
83. Zhang, Y., J. H. Ohyashiki, T. Takaku, N. Shimizu, and K. Ohyashiki. 2006. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br. J. Cancer 94:599-608.